combined oxidative phosphorylation deficiency 9
ORPHA: 3195092 Treatments Available
Overview
human disease
Available Treatments (2)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| coenzyme Q10 | oral capsule, 100-400mg | Dietary Supplement | 8 | 7d |
| riboflavin | oral tablet, 50-400mg | FDA Approved | 9 | 5d |
Classification & Codes
Orphanet Code
ORPHA:319509combined oxidative phosphorylation deficiency 9
| Orphanet | ORPHA:319509 |
| Treatments | 2 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO